243 related articles for article (PubMed ID: 28483976)
61. Pien-Tze-Huang protects cerebral ischemic injury by inhibiting neuronal apoptosis in acute ischemic stroke rats.
Zhang X; Zhang Y; Tang S; Yu L; Zhao Y; Ren Q; Huang X; Xu W; Huang M; Peng J
J Ethnopharmacol; 2018 Jun; 219():117-125. PubMed ID: 29550579
[TBL] [Abstract][Full Text] [Related]
62. Kv2 subunits underlie slowly inactivating potassium current in rat neocortical pyramidal neurons.
Guan D; Tkatch T; Surmeier DJ; Armstrong WE; Foehring RC
J Physiol; 2007 Jun; 581(Pt 3):941-60. PubMed ID: 17379638
[TBL] [Abstract][Full Text] [Related]
63. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
[TBL] [Abstract][Full Text] [Related]
64. Syntaxin-1A binds to and modulates the Slo calcium-activated potassium channel via an interaction that excludes syntaxin binding to calcium channels.
Cibulsky SM; Fei H; Levitan IB
J Neurophysiol; 2005 Mar; 93(3):1393-405. PubMed ID: 15496493
[TBL] [Abstract][Full Text] [Related]
65. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Chen D; Lee J; Gu X; Wei L; Yu SP
ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
[TBL] [Abstract][Full Text] [Related]
66. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor.
Sun FY; Guo X
J Neurosci Res; 2005 Jan 1-15; 79(1-2):180-4. PubMed ID: 15573409
[TBL] [Abstract][Full Text] [Related]
67. BMS-204352: a potassium channel opener developed for the treatment of stroke.
Jensen BS
CNS Drug Rev; 2002; 8(4):353-60. PubMed ID: 12481191
[TBL] [Abstract][Full Text] [Related]
68. Discovery of 2-Ethoxy-5-isobutyramido-
Zhou J; Wang W; Liu D; Xu S; Wang X; Zhang X; Wang X; Li Y; Sheng L; Wang X; Xu B
J Med Chem; 2024 Jan; 67(1):213-233. PubMed ID: 38150670
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of Kv2.1 Potassium Channels by MiDCA1, A Pre-Synaptically Active PLA
Schütter N; Barreto YC; Vardanyan V; Hornig S; Hyslop S; Marangoni S; Rodrigues-Simioni L; Pongs O; Dal Belo CA
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31212818
[TBL] [Abstract][Full Text] [Related]
70. Regulation of apoptotic potassium currents by coordinated zinc-dependent signalling.
Redman PT; Hartnett KA; Aras MA; Levitan ES; Aizenman E
J Physiol; 2009 Sep; 587(Pt 18):4393-404. PubMed ID: 19622611
[TBL] [Abstract][Full Text] [Related]
71. Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome.
Wang YC; Galeffi F; Wang W; Li X; Lu L; Sheng H; Hoffmann U; Turner DA; Yang W
Exp Neurol; 2020 Apr; 326():113206. PubMed ID: 31962128
[TBL] [Abstract][Full Text] [Related]
72. Mode of action of S-methyl-N, N-diethylthiocarbamate sulfoxide (DETC-MeSO) as a novel therapy for stroke in a rat model.
Mohammad-Gharibani P; Modi J; Menzie J; Genova R; Ma Z; Tao R; Prentice H; Wu JY
Mol Neurobiol; 2014 Oct; 50(2):655-72. PubMed ID: 24573692
[TBL] [Abstract][Full Text] [Related]
73. Lessons from Recent Advances in Ischemic Stroke Management and Targeting Kv2.1 for Neuroprotection.
Yeh CY; Schulien AJ; Molyneaux BJ; Aizenman E
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854248
[TBL] [Abstract][Full Text] [Related]
74. Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke.
Peng T; Britton GL; Kim H; Cattano D; Aronowski J; Grotta J; McPherson DD; Huang SL
CNS Neurosci Ther; 2013 Oct; 19(10):773-84. PubMed ID: 23981565
[TBL] [Abstract][Full Text] [Related]
75. Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1.
Dallas ML; Boyle JP; Milligan CJ; Sayer R; Kerrigan TL; McKinstry C; Lu P; Mankouri J; Harris M; Scragg JL; Pearson HA; Peers C
FASEB J; 2011 May; 25(5):1519-30. PubMed ID: 21248240
[TBL] [Abstract][Full Text] [Related]
76. Central nervous system agents for ischemic stroke: neuroprotection mechanisms.
Pandya RS; Mao L; Zhou H; Zhou S; Zeng J; Popp AJ; Wang X
Cent Nerv Syst Agents Med Chem; 2011 Jun; 11(2):81-97. PubMed ID: 21521165
[TBL] [Abstract][Full Text] [Related]
77. An in silico investigation of Kv2.1 potassium channel: Model building and inhibitors binding sites analysis.
Wang X; Zhang X; Zhou J; Wang W; Wang X; Xu B
Mol Inform; 2023 Dec; 42(12):e202300072. PubMed ID: 37793122
[TBL] [Abstract][Full Text] [Related]
78. Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke.
Lapchak PA; Schubert DR; Maher PA
J Neurochem; 2011 Jan; 116(1):122-31. PubMed ID: 21054387
[TBL] [Abstract][Full Text] [Related]
79. Current status and perspectives on the development of neuroprotectants for ischemic cerebrovascular disease.
Hong H; Liu GQ
Drugs Today (Barc); 2003 Mar; 39(3):213-22. PubMed ID: 12730705
[TBL] [Abstract][Full Text] [Related]
80. An MD2-perturbing peptide has therapeutic effects in rodent and rhesus monkey models of stroke.
Fang Z; Wu D; Deng J; Yang Q; Zhang X; Chen J; Wang S; Hu S; Hou W; Ning S; Ding Y; Fan Z; Jiang Z; Kang J; Liu Y; Miao J; Ji X; Dong H; Xiong L
Sci Transl Med; 2021 Jun; 13(597):. PubMed ID: 34108252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
